Singh K - Search Results

1

Maintaining surgical care delivery during the COVID-19 pandemic: A comparative cohort study at a tertiary gynecological cancer centre.

Leung E, Pervaiz Z, Lowe-Zinola J, Cree S, Kwong A, Marriott N, Cole F, Arum U, Szopinski B, Elattar A, Sundar S, Kehoe S, Singh K, Balega J, Yap J. Leung E, et al. Among authors: singh k. Gynecol Oncol. 2021 Mar;160(3):649-654. doi: 10.1016/j.ygyno.2020.12.013. Epub 2020 Dec 16. Gynecol Oncol. 2021. PMID: 33358197 Free PMC article.

2

Reporting 'Denominator' data is essential for benchmarking and quality standards in ovarian cancer.

Phillips A, Balega J, Nevin J, Singh K, Elattar A, Kehoe S, Sundar S. Phillips A, et al. Among authors: singh k. Gynecol Oncol. 2017 Jul;146(1):94-100. doi: 10.1016/j.ygyno.2017.04.007. Epub 2017 Apr 12. Gynecol Oncol. 2017. PMID: 28411948 Free article.

3

Prolonged interruption of chemotherapy in patients undergoing delayed debulking surgery for advanced high grade serous ovarian cancer is associated with a worse prognosis.

Searle G, Pounds R, Phillips A, Kehoe S, Balega J, Singh K, Yap J. Searle G, et al. Among authors: singh k. Gynecol Oncol. 2020 Jul;158(1):54-58. doi: 10.1016/j.ygyno.2020.04.048. Epub 2020 Apr 25. Gynecol Oncol. 2020. PMID: 32345546

4

The NICE classification for 'Ultra-radical (extensive) surgery for advanced ovarian cancer' guidance does not meaningfully predict postoperative complications: a cohort study.

Phillips A, Sundar S, Singh K, Pounds R, Nevin J, Kehoe S, Balega J, Elattar A. Phillips A, et al. Among authors: singh k. BJOG. 2019 Jan;126(1):96-104. doi: 10.1111/1471-0528.15423. Epub 2018 Sep 9. BJOG. 2019. PMID: 30092615

5

Patient-Reported Outcomes After Extensive (Ultraradical) Surgery for Ovarian Cancer: Results From a Prospective Longitudinal Feasibility Study.

Soo Hoo S, Marriott N, Houlton A, Nevin J, Balega J, Singh K, Yap J, Sethuram R, Elattar A, Luesley D, Kehoe S, Sundar S. Soo Hoo S, et al. Among authors: singh k. Int J Gynecol Cancer. 2015 Nov;25(9):1599-607. doi: 10.1097/IGC.0000000000000551. Int J Gynecol Cancer. 2015. PMID: 26397157

6

Predictive value of the age-adjusted Charlston co-morbidity index on peri-operative complications, adjuvant chemotherapy usage and survival in patients undergoing debulking surgery after neo-adjuvant chemotherapy for advanced epithelial ovarian cancer.

Phillips A, Singh K, Pounds R, Sundar S, Kehoe S, Nevin J, Elattar A, Balega J. Phillips A, et al. Among authors: singh k. J Obstet Gynaecol. 2017 Nov;37(8):1070-1075. doi: 10.1080/01443615.2017.1324413. Epub 2017 Jul 25. J Obstet Gynaecol. 2017. PMID: 28741395

7

Complete cytoreduction after five or more cycles of neo-adjuvant chemotherapy confers a survival benefit in advanced ovarian cancer.

Phillips A, Sundar S, Singh K, Nevin J, Elattar A, Kehoe S, Balega J. Phillips A, et al. Among authors: singh k. Eur J Surg Oncol. 2018 Jun;44(6):760-765. doi: 10.1016/j.ejso.2018.01.097. Epub 2018 Jan 31. Eur J Surg Oncol. 2018. PMID: 29426779 Free article.

8

Diaphragm disease in advanced ovarian cancer: Predictability of pre-operative imaging and safety of surgical intervention.

Pounds R, Phillips A, Kehoe S, Nevin J, Sundar S, Elattar A, Teo HG, Singh K, Balega J. Pounds R, et al. Among authors: singh k. Eur J Obstet Gynecol Reprod Biol. 2018 Jul;226:47-53. doi: 10.1016/j.ejogrb.2018.05.024. Epub 2018 May 18. Eur J Obstet Gynecol Reprod Biol. 2018. PMID: 29807350 Free article.

9

Socioeconomic differences impact overall survival in advanced ovarian cancer (AOC) prior to achievement of standard therapy.

Phillips A, Kehoe S, Singh K, Elattar A, Nevin J, Balega J, Pounds R, Elmodir A, Pascoe J, Fernando I, Sundar S. Phillips A, et al. Among authors: singh k. Arch Gynecol Obstet. 2019 Nov;300(5):1261-1270. doi: 10.1007/s00404-019-05269-8. Epub 2019 Aug 14. Arch Gynecol Obstet. 2019. PMID: 31414175

10

Serum Albumin as a Predictor of Survival after Interval Debulking Surgery for Advanced Ovarian Cancer (AOC): A Retrospective Study.

Dai D, Balega J, Sundar S, Kehoe S, Elattar A, Phillips A, Singh K. Dai D, et al. Among authors: singh k. J Invest Surg. 2022 Feb;35(2):426-431. doi: 10.1080/08941939.2020.1827314. Epub 2020 Oct 6. J Invest Surg. 2022. PMID: 33021127

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

9,428 results

Search Page